IJGC Podcast

By BMJ GroupMedicine Health & Fitness

IJGC Podcast episodes

February 21, 2022 The FeMMe Trial with Drs. Andreas Obermair and Monika Janda
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Andreas Obermair and Monika Janda to discuss the FeMMe trial.
Highlights:
feMMe was a randomised phase 2 trial testing LNG-IUD alone or in combination with a weight loss intervention or metformin for endometrial hyperplasia with atypia or stage 1 endometrial cancer.
Overall complete pathological response at 6 month was 61%.
Women with endometrial hyperplasia with atypia responded much better than women with endometrial cancer.
Weight loss achieved was moderate and BMI was not associated with response – more work on weight loss interventions needed.
Metformin did not improve response – more biomarker research is needed to understand who will respond to LNG-IUD or not.
49 min
February 11, 2022 Reviewing the February Issue with Felix Boria (Spanish version)
In this episode of the IJGC Podcast, Editorial Fellow Felix Boria discusses the contents of the February issue of IJGC in Spanish.
17 min
February 11, 2022 Reviewing the February Issue with Floriane Jochum and Natalie Medley (English version)
In this episode of the IJGC Podcast, Editorial Fellows Floriane Jochum and Natalie Medley discuss the contents of the February issue of IJGC in English.
17 min
February 08, 2022 Legends in Gynecologic Oncology: David Gershenson
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. David M. Gershenson to discuss legends in gynecologic oncology. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research or rare ovarian cancers.
Highlights:
Mentoring is an essential component of a successful career in gynecologic oncology, and every trainee should seek a mentor early in their fellowship.
Strive to achieve the optimal work/life balance to avoid burnout over the course of your career.
The subspecialty of gynecologic oncology has been consistently gratifying for me during the past 40+ years. It provides young trainees with a myriad of wonderful opportunities and career choices.
I strongly recommend having a 5-year plan to optimize success in your professional career.
30 min
February 04, 2022 SUCCOR: Cone Before Radical Hysterectomy
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Enrique Chacón and Luis Chiva to discuss the possible protective role of conization.
35 min
February 03, 2022 Reviewing the February Issue with Irina Tsibulak (Russian version)
In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.
17 min
January 31, 2022 Reviewing the January Issue with Irina Tsibulak (Russian version)
In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.
15 min
January 27, 2022 ESGO Quality Indicators in Endometrial Cancer with Nicole Concin
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the article European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. Dr. Concin is a gynaecological oncologist, ESGO president, Co-Chair of ENGOT Early Drug Development Network, and Professor at Medical University of Innsbruck, Innsbruck Austria & Kliniken Essen-Mitte, Essen, Germany.
Related Link: https://ijgc.bmj.com/content/31/12/1508
46 min
January 21, 2022 The DESKTOP III Trial with Philipp Harter
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial. Prof. Harter is the director of the Department of Gynecology & Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany, and the chair of the AGO Study Group.
Highlights:
-Role of surgery for relapsed ovarian cancer is under debate
-DESKTOP III has shown a significant benefit regarding PFS and OS by secondary cytoreduction
-The data, interpretation and clinical consequences are discussed".
42 min
January 14, 2022 IRTA: Open vs MIS Radical Trachelectomy with Gloria Salvo and Rene Pareja
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Gloria Salvo and Dr. Rene Pareja to discuss IRTA: Open vs MIS Radical Trachelectomy. Dr. Salvo was trained as a gynecologist in Hospital Italiano de Buenos Aires, Argentina and works as a Clinical Reviewer/Data Abstractor of the Neuroendocrine Cervical Tumor Registry (NeCTuR) at MD Anderson Cancer Center. She has published several articles in cervical cancer including sentinel lymph node mapping and fertility-sparing surgery, neuroendocrine cervical carcinomas, and is the first author of the IRTA Study.
Highlights
-In this multicenter retrospective study, we found no difference in the 4.5-year DFS rates between open radical trachelectomy and minimally invasive radical trachelectomy in patients with tumors up to 2 cm, even after adjusting for potential confounding variables because of unbalanced groups.
-There was no difference in the OS rates or recurrence rates between the open surgery and MIS groups.
-Risk factors for relapse were more common in the open surgery group, but oncologic outcomes were similar for the open and minimally invasive approaches.
41 min

About IJGC Podcast

From the publisher's feed

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer.